Molecular characterization of respiratory syncytial viruses infecting children reported to have received palivizumab immunoprophylaxis

BACKGROUND: Respiratory syncytial virus (RSV) is a major cause of respiratory infections in children. Palivizumab (PZ) is the only RSV-specific immunoprophylaxis approved by the U.S. Food and Drug Administration. Mutations leading to amino acid substitutions in the PZ binding site of the RSV F prote...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Clin Virol
Autori principali: Oliveira, Danielle B.L., Iwane, Marika K., Prill, Mila M., Weinberg, Geoffrey A., Williams, John V., Griffin, Marie R., Szilagyi, Peter G., Edwards, Kathryn M., Staat, Mary A., Hall, Caroline B., Durigon, Edison L., Erdman, Dean D.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Elsevier Science 2015
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7172275/
https://ncbi.nlm.nih.gov/pubmed/25766983
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcv.2015.01.016
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi